These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 619025)

  • 21. Improvement in central monoamine metabolism in adult coeliac patients starting a gluten-free diet.
    Hallert C; Sedvall G
    Psychol Med; 1983 May; 13(2):267-71. PubMed ID: 6192458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
    Massarotti M; Migliore A; Roccella P; Toffano G
    Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
    [No Abstract]   [Full Text] [Related]  

  • 23. [Homovanillic acid and 5--hydroxy-indoleacetic acid in the cerebrospinal fluid of man--concentration gradients between lumbar and ventricular CSF and variations in ventricular CSF-- (author's transl)].
    Inagawa T; Kajihara S; Okada Y; Yoshimoto H; Mori S; Ishikawa S; Uozumi T
    No To Shinkei; 1978 May; 30(5):565-74. PubMed ID: 666924
    [No Abstract]   [Full Text] [Related]  

  • 24. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.
    Inagawa T; Ishikawa S; Uozumi T
    J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z
    Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract]   [Full Text] [Related]  

  • 26. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
    Sourkes TL
    Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results.
    Maira G; Bareggi SR; Di Rocco C; Calderini G; Morselli PL
    J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):123-8. PubMed ID: 1151392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms.
    Banki CM; Molnar G; Vojnik M
    J Affect Disord; 1981 Jun; 3(2):91-9. PubMed ID: 6166645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 1. Background variables.
    Banki CM; Vojnik M; Molnar G
    J Affect Disord; 1981 Jun; 3(2):81-9. PubMed ID: 6166644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual averaged evoked responses in psychiatric patients. Relationship to levels of 5-hydroxy-indoleacetic acid, homovanilic acid and tryptophan in cerebrospinal fluid.
    Perris C; Gottfries CG; von Knorring L
    J Psychiatr Res; 1979; 15(3):175-81. PubMed ID: 94355
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Homovanillic (HVA) and 5-hydroxyindoleacetic (5-HIAA) acid concentration in the cerebrospinal fluid of patients with supratentorial tumors and symptoms of intracranial hypertension (preliminary report)].
    Majchrzak H; Kmieciak-Kołada K; Herman Z; Wencel T
    Neurol Neurochir Pol; 1980; 14(1):87-90. PubMed ID: 6154903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurophysiological measures related to levels of 5-hydroxyindoleacetic acid, homovanillic acid and tryptophan in cerebrospinal fluid of psychiatric patients.
    Gottfries CG; von Knorring L; Perris C
    Neuropsychobiology; 1976; 2(1):1-8. PubMed ID: 1004696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report.
    Shaywitz BA; Cohen DJ; Bowers MB
    J Pediatr; 1977 Jan; 90(1):67-71. PubMed ID: 830896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.
    Banki CM; Molnar G; Fekete I
    Arch Psychiatr Nervenkr (1970); 1981; 229(4):345-53. PubMed ID: 6164353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parallel variation of homovanillic acid and 5-hydroxyindoleacetic acid in ventricular cerebrospinal fluid of man.
    Inagawa T; Mori S; Yoshimoto H; Ishikawa S; Uozumi T
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):79-87. PubMed ID: 1026667
    [No Abstract]   [Full Text] [Related]  

  • 38. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 40. Similar effects of tryptophan and sleep on cisternal cerebrospinal fluid 5-hydroxyindoleacetic and homovanillic acids in cats.
    Radulovacki M; Buckingham RL; Chen EH; Kovacević R
    Brain Res; 1977 Jul; 129(2):371-4. PubMed ID: 884510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.